Avalyn Pharma Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2017-05-24. The offering totals $64.9M, of which $18.2M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 39 people.
| Name | Role | Location |
|---|---|---|
| Tiba W Aynechi | Director | Seattle, WA |
| Jonathan W Leff, M.D. | Director | Seattle, WA |
| Bruce W Montgomery, M.D. | Director | Seattle, WA |
| Niall W O'Donnell | Director | Seattle, WA |
| Ketan W Patel | Director | New Haven, CT |
| Heather W Preston | Director | Seattle, WA |
| Naveed W Siddiqi | Director | Seattle, WA |
| Bruce W Montgomery, M.D. | Executive Officer | Seattle, WA |
| Mark W Surber, Ph.D. | Executive Officer | Seattle, WA |
| Tiba Aynechi | Director | South San Francisco, CA |
| Niall O'Donnell | Director | St. Louis, MO |
| Daniel D Burgess | Director | Sacramento, CA |
| Ketan Patel | Director | Cambridge, MA |
| Jonathan Leff | Director | Ness Ziona, L3 |
| Lyn Baranowski | Director | Seattle, WA |
| Lyn Baranowski | Executive Officer | Seattle, WA |
| Peter Moldt | Director | Seattle, WA |
| Cassandra Gianna Luca | Director | Seattle, WA |
| Jill Gianna Carroll | Director | Seattle, WA |
| Michael J Kamdar | Director | San Diego, CA |
| Michael J Kamdar | Executive Officer | San Diego, CA |
| A. Bruce Montgomery | Director | Seattle, WA |
| A. Bruce Montgomery | Executive Officer | Seattle, WA |
| Niall Bruce O'Donnell | Director | Seattle, WA |
| Jonathan Bruce Leff | Director | Seattle, WA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-10-10 | D | $189.2M | $189.2M |
| 2020-05-08 | D | $35.7M | $35.5M |
| 2017-03-24 | D | $62.9M | $16.6M |
| 2015-08-12 | D/A | $2.2M | $2.2M |
| 2015-03-24 | D/A | $2.0M | $1.7M |
| 2012-11-16 | D | $1.2M | $1.1M |